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Abstract
Purpose The study was designed to investigate whether se-
rum concentrations of leptin, resistin and adiponectin in obese
and normal-weight patients with primary knee osteoarthritis
(OA) correlate with clinical and radiological stages of the
disease and percentage of total body fat.
Methods Seventy-three patients with knee OA, divided into
obese and normal-weight groups, were clinically evaluated
according to the Knee Society Score (KSS), and radiologically
assessed using Kellgren and Lawrence scale. The percentage
of total body fat and some anthropometric data were also
given. Serum leptin, resistin and adiponectin concentrations
were measured by Elisa and were correlated with the clinical,
radiological and anthropometric parameters.
Results Leptin concentrations were significantly higher
(p = 0.001) in the obese patients and positively correlated
(R = 0.63) with radiologically assessed OA grade, but only
in the normal-weight group. Resistin and adiponectin concen-
trations were identical in obese and normal-weight patients
and negatively correlated (R = −0.41) with the clinical status
of obese patients. In both groups, percentage of total body fat
positively correlated (R = 0.29 and R = 0.53 for obese and
normal-weight respectively) with radiologically assessed OA
grade. However, no correlations were found with clinical sta-
tus of the patients.
Conclusions It was found that in the obese patients with knee
OA, increased percentage of total body fat and elevated serum
leptin concentration might favour the advancement of clinical
but not radiologically assessed changes in the joint structures,
while in normal-weight patients it correlates only with radio-
logically assessed changes but does not affect to an apprecia-
ble extent the clinical status of the patients.
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Introduction
Osteoarthritis (OA) is a multivariate degenerative disease of sy-
novial joints resulting from both mechanical and biological fac-
tors, among which sex, age, genetic factors, trauma and obesity
play the most important role [1]. The influence of obesity on the
development of OAwas recognised either in respect to the me-
chanical load leading to increased feasibility of damage of the
joint structures [2], or as a result of activation of mechanorecep-
tors on cartilage surface, which in turn can lead to the synthesis of
the inflammatory mediators [3]. In the mid-1990s, due to the
discovery of leptin, the first adipocyte-derived cytokine [4], it
has been shown that the white adipose tissue (WAT) produces
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several substances, called adipocytokines, which can act similar-
ly to the classic endocrine hormones. Adipocytokines were
recognised as modulators of the energy homeostasis, as well as
an immunological, haemostatic and inflammatory processes [5].
Those substances also play an important role in the degradation
processes of cartilage, bone and synovium [6]. Since their effect
on the degenerative changes in non-loaded joints were demon-
strated [7], they might provide a link between obesity and OA.
Among adipocytokines, leptin, resistin and adiponectin were the
most extensively studied [8].
Human leptin is encoded by the obese gene (OB) and
its activity is mediated by the OB receptor encoded by the
diabetes gene (DB). Leptin is produced mainly by adipo-
cytes of the subcutaneous white adipose tissue (WAT), as
well as by the glandular cells of the stomach, liver and
mammary gland [9]. It acts on the central nervous system
regulating energy balance by inhibiting hunger, increasing
energy expenditure and thermogenesis. It also demon-
strates similarity to the action of insulin in the ability to
lower blood glucose level [10]. Leptin pro-inflammatory
effect depends on stimulation of the T-lymphocytes. This
in turn increases the levels of TNF-α and interleukins,
which precedes the activation the of the NK cells, macro-
phages and neutrophils [11].
Resistin, encoded by the RSTN gene, is produced mainly in
the WAT, as well as in the bone marrow, spleen, lungs, placenta
and pancreas. Resistin increases the secretion of proinflammatory
cytokines (TNF-α, IL-6 and IL-12) by macrophages [12]. Intra-
articular injection of resisitin in mice, resulted in joint inflamma-
tion, resembling human arthritis [13]. Apart from the inflamma-
tory processes, it also plays a role in adipogenesis and shows a
positive correlation with insulin resistance and obesity [14].
Adiponectin, encoded by the ADPOQ gene, is produced by
the WAT and visceral adipose tissue and is implicated in carbo-
hydrate and lipid metabolism, and thermoregulation. It also in-
creases cell sensitivity to insulin in muscle and liver. The
concentration of adiponectin in plasma is higher in females and
correlates with degenerative join diseases and rheumatoid arthri-
tis [15, 16]. Less information is available on the effect of
adiponectin in the inflammatory processes, although its role in
interleukins (IL-1β, IL-6), metaloproteins (MMP-13, MMP-1
and MMP-3) and nitric oxide (NO) secretion was reported [17].
To date, very few investigations have been made on the
effects of these adipocytokines on the radiological features
and clinical status of the patients with knee OA.
We hypothesised that there might be a correlation between
serum concentration of leptin, resistin and adiponectin, total
body fat, and the radiological and clinical advancement of
changes in the knee joints in patients with primary OA.
Materials and methods
From a total of 186 patients with knee OA treated in the
Department of Orthopaedics and Traumatology, a group of 73
patients with primary OAwas carefully selected, according to the
criteria developed by the American College of Rheumatology
[18]. Individuals with any evidence of secondary OA, inflamma-
tory arthritis and those with neurological conditions were exclud-
ed from the study, along with subjects with acute or chronic renal
disease, metabolic syndrome, heart diseases and epilepsy. Fifty-
six patients with body mass index (BMI) ≥30 were included in
the obese group (group I) while 17 patients with normal BMI
were included in the normal-weight group (group II). The knee
radiographs were evaluated by two independent orthopaedists
usingKellgren–Lawrence criteria [19]. The clinical advancement
of OA was assessed with the Knee Society Score [20]. The
anthropometric characteristics of the patients are summarised in
Table 1. The research Ethics Board of Poznan University of
Medical Sciences approved the study (decision no. 387/13).
Anthropometric measurements were taken at the time of di-
agnosis. The patients were weighted with calibrated scale to the
Table 1 Characteristics of patients with OA
Variables Obese Normal weight
Total (n = 56) Males (n = 11) Females (n = 45) Total (n = 17) Males (n = 6) Females (n = 11)
Age 66 ± 6 68 ± 6 66 ± 6 65 ± 6 63 ± 8 66 ± 5
Weight (kg) 87.0 ± 10.7 97.1 ± 8.7 84.5 ± 9.7 66.3 ± 7.2 73.5 ± 6.1 62.4 ± 4.2
Height (cm) 161 ± 8 174 ± 8 157 ± 5 164 ± 8 173 ± 6 159 ± 5
BMI (kg/m2) 33.48 ± 3.17 32.1 ± 2.2 33.8 ± 3.3 24.6 ± 0.5 25.5 ± 0.4 24.6 ± 0.5
Waist circumference (cm) 99 ± 8 105 ± 5 98 ± 8 87 ± 5 90 ± 7 85 ± 3
Hip circumference (cm) 112 ± 8 109 ± 5 113 ± 8 100 ± 6 97 ± 7 102 ± 7
WHR 0.88 ± 0.07 0.97 ± 0.04 0.86 ± 0.06 0.86 ± 0.07 0.92 ± 0.07 0.83 ± 0.05
Values are expressed as means ± SD
BMI body mass index, WHR waist-hip ratio
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nearest 0.1 kg in minimum clothing and standing height were
measured with stadiometer. Waist and hip circumference was
measured by standard procedure and skinfolds’ thickness (bi-
ceps, triceps, subscapular and iliac crest) according to ISAK
(In te rna t iona l Soc ie ty for the Advancement of
Kinanthropometry) with a Harpenden caliper (Baty
International, Burgess Hill, UK), to the nearest 0.2 cm. The
BMI andwaist-hip ratio (WHR)were then calculated. Total body
fat was calculated fromBMI according to formulae developed by
Deurenberg et al. [21]. The equation of Durnin and Womersley
[22] was used to predict body density (BD) using the skinfold
thickness, then body fat was calculated using the equation of Siri
[23]. Body fat content was assessed by bioimpedance analysis
(BIA) using aBodystat 1500 analyser (Bodystat, Douglas, Isle of
Man) after ten minutes of rest. The analysis was performed by
the same operator for all subjects by placing two electrodes on
the right hand and right foot, with the subject in a supine position.
From all patients, fasting blood samples were obtained, serum
was separated and aliquoted into tubes (CryoPure; Sarstedt,
Nümbrecht, Germany), which were stored at −20 °C until anal-
ysis. Serum leptin, resistin and adiponectin concentrations were
determined in duplicate by an enzyme-linked immunosorbent
assay (R&D Systems;Minneapolis, MN, USA). The absorbance
was measured at 450 nm in an automated ELISA plate reader
(Infinite F50; Tecan, Männedorf, Switzerland) and the concen-
tration of adipocytokines were calculated from standard curves.
The results were statistically evaluated, and the differences were
subjected to linear regression analysis (STATISTICA 10.0;
StatSoft, Kraków, Poland).
Results
The advancement of OA changes in knee joints, determined
by radiography, using the K-L grading system, showed no
patients graded 0 in both groups. In the obese subjects (group
I), there were no patients graded 1, nine patients graded 2, 16
patients graded 3 and 31 patients graded 4. In the normal-
weight subjects (group II), there was one patient graded 1,
two patients graded 2, six patients graded 3 and eight patients
graded 4. No appreciable differences in the advancement of
changes in knee joints, estimated by the K-L, were found
between the two groups.
The evaluation of clinical advancement of OA, by the Knee
Society Score (KSS), showed a mean of 64 points (range, 20–
90) in group I and 62 points (range, 5–100) in group II. The
mean functional KSS score was 55 points (range, 5–100) in
group I and 64 points (range, 10–90) in group II. No statisti-
cally significant differences in all KSS parameters between the
groups were found.
The percentage of total body fat, estimated by BMI,
skinfolds and BIA, was significantly higher in group I than
in group II (Table 2) and in both groups it was significantly
higher in females than in males.
In both groups, the percentage of total body fat, calculated
on the basis of BMI, correlated with the radiographic advance-
ment of OA, assessed by the K-L grading system (R = 0.29,
p = 0.028 for group I, and R = 0.53, p = 0.028 for group II).
There was no correlation, however, between the percentage
of total body fat, calculated from the skinfolds’ thickness and
by the BIA.
There was also no correlation between the percentage of
total body fat and the KSS score, and the differences between
male and female patients calculated separately (not shown)
were insignificant.
In patients from group I, mean serum leptin concentration
was higher than in patients from group II (p = 0.001), in male
as well as in female patients, and in both groups, it was higher
in female than in male patients (p = 0.008 and p = 0.005 for
obese and normal-weight respectively). There were no differ-
ences in mean resistin and adiponectin levels between the two
groups, although in group I, adiponectin levels were signifi-
cantly lower compared with the normal weight group and
differed significantly (p = 0.031) between the genders, while
serum resistin levels were not significantly different in the
obese male and normal-weight female patients (Table 3).
In group I, serum leptin concentration correlated with the
BMI (R = 0.27, p = 0.041) and with the percentage of total
body fat calculated on the basis of BMI (R = 0.54,
p = 0.0001), skinfolds (R = 0.50, p = 0.0001) and BIA
Table 2 The percentage of total
body fat measured by different
methods in the obese and normal-
weight patients with knee OA













BMI 47.9 ± 6.3* 38.0 ± 3.3* 50.4 ± 3.9* 35.3 ± 5.9* 27.8 ± 1.9* 39.4 ± 1.6*
Skinfolds 39.1 ± 4.9* 31.3 ± 3.0* 41.0 ± 3.1* 33.5 ± 7.2* 25.7 ± 5.0* 37.8 ± 3.6*
BIA 43.5 ± 7.3* 31.7 ± 3.3* 46.4 ± 4.6* 33.4 ± 8.8* 23.4 ± 2.8* 39.0 ± 5.2*
Values are expressed as means ± SD
*p < 0.05 denotes difference significant
BMI body mass index, BIA bioimpedance analysis
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(R = 0.56, p = 0.0001). There was also a correlation (R = 0.29,
p = 0.0342) between serum resistin concentration and the per-
centage of total body fat, calculated on the basis of BMI, and
there were no correlations between serum adiponectin and
both BMI and percentage of body fat.
In the same group there was a negative correlation
(R = −0.41, p = 0.001) between serum resistin concentration
and the advancement of the OA estimated by the KSS score.
Unexpectedly, in this group there were no correlations be-
tween serum leptin, as well as resistin and adiponectin con-
centrations and the radiologically assessed advancement of
changes in knee joints.
In group II, serum leptin concentration positively correlated
with the percentage of total body fat, but onlywhen calculated on
the basis of BMI (R = 0.56, p= 0.0186) and skinfolds (R = 0.79,
p = 0.0002) and not BIA, while serum adiponectin concentration
positively correlated (R = 0.52, p = 0.0313) with the percentage
of total body fat, but only when calculated from the thickness of
skinfolds. In the same group, serum leptin concentration posi-
tively correlated (R = 0.63, p= 0.006) with the advancement of
the OA determined by the K-L grading system.
Discussion
Numerous studies indicate an important role of the adipose
tissue in the pathogenesis of OA [24, 25]. A correlation was
reported between obesity and increased stiffness of knee joints,
accompanied by pain [26, 27], and it was shown that the per-
centage of total body fat favours exacerbation of the inflamma-
tory processes and acceleration of the disease progress [28].
It was also demonstrated [29] that a decrease in body mass
could alleviate the pain, contributing to the improvement of
the functional KSS score, and that the reduction of body fat
(but not body mass) alleviates OA symptoms [30]. It was
postulated that cytokines, secreted from the adipose tissue—
leptin, resistin and adiponectin—might influence the progress
of OA and the gravity of the symptoms [31].
Our findings on higher leptin concentration in the obese
than in normal-weight patients of both sexes (higher in fe-
males than in males), correlated with the BMI and the
percentage of total body fat substantiating and extending ear-
lier report [32]. However, in contrast to others [33], who
showed a correlation between serum leptin levels and progress
of the disease, we did not find any correlation with the ad-
vancement of radiographic changes in knee joints, estimated
by the K-L grading system in the obese patients in agreement
with Iwamoto et al. [34] who obtained similar results.
Interestingly, in the normal-weight patients, we found a cor-
relation between serum leptin concentration and the intensity of
radiographic changes in the knee joints, smaller in the knee joints
in the normal-weight (K-L median 3) than in the obese patients
(K-L median 4). This indicates that increase in the concentration
of leptin plays a more important role in the assessment of radio-
logical changes in patients with less advanced changes in knee
joints than at the final stage of the disease.
Our results are consistent with an earlier report [35] show-
ing a lower concentration of synovial fluid leptin in patients
with advanced OA in comparison to those at the initial stages
of the disease, and with another report [36] on overexpression
of genes encoding IGF-1, TIMP-2, type II collagen andMMP-
13 in the obese patients, which might be responsible for inhi-
bition of the leptin impact on chondrocytes. These results were
confirmed in an animal model [37].
Numerous studies indicate that the local concentration of
leptin might be more important for the degeneration of joint
structures than its concentration in serum, e.g. Simopoulou
et al. [38] noted a much higher concentration of leptin in the
synovial fluid than in the serum of patients with knee OA.
Local leptin mRNA concentration was higher in obese pa-
tients than in those with normal weight, while the concentra-
tion of leptinmRNA and its receptor in joint cartilage obtained
from the Bdegenerated^ site was higher than from the
Bhealthy^ site. Moreover, two groups [39, 40] reported that
the concentration of leptin in the synovial fluid correlates with
the BMI of the patients, and one [41] that it correlates with the
intensity of knee pain.
It was shown that resistin concentration correlated with the
occurrence of synovitis, but not with the concentration of car-
tilage degeneration markers [42], and a correlation between
serum resistin concentration, erythrocyte sedimentation rate
(ESR) and C-reactive protein (CRP) was described in patients
Table 3 Serum adipocytokine concentration in the obese and normal-weight patients with OA
Adipocytokine Obese Normal weight
Total (n = 56) Males (n = 11) Females (n = 45) Total (n = 17) Males (n = 6) Females (n = 11)
Leptin (ng/ml) 47.99 ± 40.18* 18.71 ± 9.45* 55.15 ± 41.60* 16.49 ± 14.9* 3.86 ± 3.88* 23.38 ± 14.14*
Resistin (pg/ml) 8.16 ± 4.89 7.54 ± 5.11 8.31 ± 4.88 8.47 ± 11.16 11.35 ± 18.53 6.89 ± 4.46
Adiponectin (ng/ml) 8.08 ± 4.66 5.54 ± 2.95* 8.70 ± 4.81* 9.93 ± 4.07 8.03 ± 3.26 10.97 ± 4.23
Concentrations of adipocytokines are expressed as means ± SD
*p < 0.05 denotes difference significant between obese and normal-weight patients
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with OA [43]. In addition, the results of other studies [44, 45]
suggested that there is a correlation between resistin concen-
tration and the degree of clinical progress of hand OA.
Although the elevated level of serum resistin was also report-
ed in rheumatoid arthritis [46], others [42] did not find any
correlation between serum and synovial fluid concentration of
resistin and BMI of the patients with knee OA.
In our study, a negative correlation between serum resistin
concentration and the advancement of the degenerative chang-
es in knee joints, evaluated by radiography, was found in the
obese patients. However, there were no convincing informa-
tion on the effects of local concentration of resistin on the
radiographic changes in knee joints.
Studies made in patients gave conflicting results regarding
the relation of serum adiponectin concentration to the knee
OA. A positive correlation between the concentration of
adiponectin and the advancement of OA, estimated by the
Ahlbäck scale was observed [47] and higher concentration
of adiponectin in patients with more advanced osteoarthritis
of hand joints was reported [45]. However, others [48] found a
negative correlation between the concentration of serum
adiponectin and the advancement of the degenerative changes
in knee joints estimated by the K-L grading system.
In conclusion, we confirmed earlier reports on higher se-
rum leptin concentration in the obese group of patients with
OA compared with the normal-weight group. In the obese
patients, elevated serum leptin positively correlated with the
BMI and total body fat, but there were no correlations between
both the clinical status and the advancement of radiologically
assessed changes in the knee joints of the obese patients. In
these patients, there was a negative correlation between serum
resistin concentration and the advancement of the degenera-
tive changes in knee joints, evaluated by radiography. This
might imply that resistin slows down the advancement of the
degenerative changes in knee joints. This suggestion, howev-
er, can bemisleading since in the present report we determined
serum resistin concentration and local concentration of resistin
had not been measured.
In the normal weight patients, we found a correlation be-
tween serum leptin concentration and the advancement of ra-
diological changes in knee joints, estimated by the K-L grad-
ing system, suggesting that serum concentration of leptin is
more important in the evaluation of changes in the knee joints
at the earlier stages than at the final stage of the disease.
In the present study, no differences were found in serum
adiponectin concentration between obese and normal-weight
patients. Numerous reports from the literature on the effect of
adipocytokines on the advancement of changes in knee joints
in the obese OA patients often gave conflicting results.
Therefore, in order to more precisely define the role of
adipocytokines in the origin and advancement of pathological
processes in osteoarthritic knee joints in the obese patients,
accompanying diseases, such as a metabolic syndrome or
diabetes type II, frequent in these patients, should be taken
into account.
Our results, although interesting from the point of view of
basic science, have only a minor meaning for the clinical
practice. In order to make our results suitable for clinical prac-
tice, further investigations on the effects of local
adipocytokine concentration on the advancement of changes
in the knee joints are required.
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